Trajectories of humoral and cellular immunity and responses to a third dose of mRNA vaccines against SARS-CoV-2 in patients with a history of anti-CD20 therapy

BACKGROUND: The majority of patients with B-cell-depleting therapies show compromised vaccination-induced immune responses. Herein, we report on the trajectories of anti-SARS-CoV-2 immune responses in patients of the RituxiVac study compared with healthy volunteers and investigate the immunogenicity...

Descripción completa

Detalles Bibliográficos
Autores principales: Sidler, Daniel, Born, Alexander, Schietzel, Simeon, Horn, Michael P, Aeberli, Daniel, Amsler, Jennifer, Möller, Burkhard, Njue, Linet M, Medri, Cesare, Angelillo-Scherrer, Anne, Borradori, Luca, Seyed Jafari, S. Morteza, Radonjic-Hoesli, Susanne, Chan, Andrew, Hoepner, Robert, Bacher, Ulrike, Mani, Laila-Yasmin, Iype, Joseena Mariam, Suter-Riniker, Franziska, Staehelin, Cornelia, Nagler, Michael, Hirzel, Cedric, Maurer, Britta, Moor, Matthias B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Infections
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971359/
https://www.ncbi.nlm.nih.gov/pubmed/35361691
http://dx.doi.org/10.1136/rmdopen-2021-002166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971359/
https://www.ncbi.nlm.nih.gov/pubmed/35361691
http://dx.doi.org/10.1136/rmdopen-2021-002166

Ejemplares similares